ICI-190,622

ICI-190,622 is a drug that was developed by Imperial Chemical Industries (ICI) and is known for its anti-inflammatory properties. It is a nonsteroidal anti-inflammatory drug (NSAID) that was never marketed.

History[edit | edit source]

ICI-190,622 was developed by the British company Imperial Chemical Industries, which is now part of AstraZeneca. The drug was developed as part of a research program into anti-inflammatory drugs, but it was never brought to market.

Pharmacology[edit | edit source]

As a nonsteroidal anti-inflammatory drug, ICI-190,622 works by reducing substances in the body that cause pain and inflammation. It is similar to other NSAIDs in its mechanism of action, but its exact pharmacological properties are not well known due to its limited development.

Research[edit | edit source]

Although ICI-190,622 was never marketed, it has been used in scientific research. Studies have investigated its anti-inflammatory effects and compared it to other NSAIDs. However, the results of these studies have not led to its use in clinical practice.

See also[edit | edit source]

ICI-190,622 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.